IR@PKUHSC  > 北京大学第二临床医学院  > 肝病科
学科主题临床医学
alpha-2-HS-glycoprotein is a potential marker predicting hepatitis B e antigen seroconversion in patients with chronic hepatitis B during treatment with pegylated interferon alfa-2b
Ma Hui; Wang JiangHua; Guo Fang; Wei Lai
关键词alpha-2-HS-glycoprotein pegylated interferon alfa-2b chronic hepatitis B
刊名SCIENCE CHINA-LIFE SCIENCES
2011
DOI10.1007/s11427-010-4111-4
54期:1页:39-47
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Biology
研究领域[WOS]Life Sciences & Biomedicine - Other Topics
关键词[WOS]HEPATOCELLULAR-CARCINOMA ; PROTEOMIC ANALYSIS ; INSULIN-RECEPTOR ; CONTROLLED TRIAL ; TYROSINE KINASE ; GROWTH-FACTOR ; CIRRHOSIS ; LIVER ; SERUM ; IDENTIFICATION
英文摘要

The efficacy of interferon (IFN) is limited in about 1/3 of patients with chronic hepatitis B (CHB). We used two-dimensional electrophoresis (2-DE)-based proteomic strategies to identify potential serum markers predicting hepatitis B e antigen (HBeAg) seroconversion in these patients during IFN therapy. Two groups of patients were enrolled: training and validation. In the training group, 2-DE experiments and subsequent identification of altered levels of proteins showed that alpha-2-HS-glycoprotein, leucine-rich alpha-2-glycoprotein, and haptoglobin were significantly upregulated as compared with baseline levels in the HBeAg seroconversion group, whereas apolipoprotein C-III precursor, leucine-rich alpha-2-glycoprotein, and alpha-albumin were downregulated in the non-seroconversion group. For patients with HBeAg seroconversion in the training group, Western blot analyses showed that alpha-2-HS-glycoprotein levels in 75% of patients were significantly upregulated at the end of the treatment as compared with baseline levels. Subsequent experiments in the validation group showed that alpha-2-HS-glycoprotein levels were significantly increased at week 4 in 83.33% of patients in the HBeAg seroconversion group. Dynamic changes in the serum level of alpha-2-HS-glycoprotein may be a potential early marker for predicting HBeAg seroconversion during IFN treatment for CHB.

语种英语
WOS记录号WOS:000286470400006
项目编号2005CB522902 ; 2007CB512900 ; 2006AA02A410 ; 30901256 ; 7102153 ; 2008ZX10002-012 ; 2008ZX10002-013 ; RDC 2009-13
资助机构National Basic Research Program of China ; National High Technology Research and Development Program of China ; National Natural Science Foundation of China ; Beijing Natural Science Foundation ; National Science and Technology Major Project for Infectious Diseases Control ; Peking University People&prime ; s Hospital ; Ministry of Health of China
引用统计
被引频次:4[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/67821
专题北京大学第二临床医学院_肝病科
北京大学第二临床医学院_北京大学肝病研究所
作者单位Peking Univ, Inst Hepatol, Peoples Hosp, Beijing 100044, Peoples R China
推荐引用方式
GB/T 7714
Ma Hui,Wang JiangHua,Guo Fang,et al. alpha-2-HS-glycoprotein is a potential marker predicting hepatitis B e antigen seroconversion in patients with chronic hepatitis B during treatment with pegylated interferon alfa-2b[J]. SCIENCE CHINA-LIFE SCIENCES,2011,54(1):39-47.
APA Ma Hui,Wang JiangHua,Guo Fang,&Wei Lai.(2011).alpha-2-HS-glycoprotein is a potential marker predicting hepatitis B e antigen seroconversion in patients with chronic hepatitis B during treatment with pegylated interferon alfa-2b.SCIENCE CHINA-LIFE SCIENCES,54(1),39-47.
MLA Ma Hui,et al."alpha-2-HS-glycoprotein is a potential marker predicting hepatitis B e antigen seroconversion in patients with chronic hepatitis B during treatment with pegylated interferon alfa-2b".SCIENCE CHINA-LIFE SCIENCES 54.1(2011):39-47.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Ma Hui]的文章
[Wang JiangHua]的文章
[Guo Fang]的文章
百度学术
百度学术中相似的文章
[Ma Hui]的文章
[Wang JiangHua]的文章
[Guo Fang]的文章
必应学术
必应学术中相似的文章
[Ma Hui]的文章
[Wang JiangHua]的文章
[Guo Fang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。